DE60305018D1 - Citalopram zur behandlung von bluthochdruck - Google Patents

Citalopram zur behandlung von bluthochdruck

Info

Publication number
DE60305018D1
DE60305018D1 DE60305018T DE60305018T DE60305018D1 DE 60305018 D1 DE60305018 D1 DE 60305018D1 DE 60305018 T DE60305018 T DE 60305018T DE 60305018 T DE60305018 T DE 60305018T DE 60305018 D1 DE60305018 D1 DE 60305018D1
Authority
DE
Germany
Prior art keywords
citalopram
treatment
high pressure
blood pressure
blood high
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60305018T
Other languages
English (en)
Other versions
DE60305018T2 (de
Inventor
S Gabor
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Egyt Gyogyszervegyeszeti Gyar
Egis Pharmaceuticals PLC
Original Assignee
Egyt Gyogyszervegyeszeti Gyar
Egis Pharmaceuticals PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Egyt Gyogyszervegyeszeti Gyar, Egis Pharmaceuticals PLC filed Critical Egyt Gyogyszervegyeszeti Gyar
Application granted granted Critical
Publication of DE60305018D1 publication Critical patent/DE60305018D1/de
Publication of DE60305018T2 publication Critical patent/DE60305018T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • External Artificial Organs (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Dental Preparations (AREA)
DE60305018T 2002-03-14 2003-03-13 Citalopram zur behandlung von bluthochdruck Expired - Fee Related DE60305018T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
HU0200980 2002-03-14
HU0200980A HU0200980D0 (de) 2002-03-14 2002-03-14
PCT/HU2003/000021 WO2003075914A1 (en) 2002-03-14 2003-03-13 Citalopram for the treatment of elevated blood pressure

Publications (2)

Publication Number Publication Date
DE60305018D1 true DE60305018D1 (de) 2006-06-08
DE60305018T2 DE60305018T2 (de) 2006-11-30

Family

ID=89980266

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60305018T Expired - Fee Related DE60305018T2 (de) 2002-03-14 2003-03-13 Citalopram zur behandlung von bluthochdruck

Country Status (35)

Country Link
US (1) US7141604B2 (de)
EP (1) EP1490049B1 (de)
JP (1) JP2005519945A (de)
KR (1) KR100718368B1 (de)
CN (1) CN1259912C (de)
AT (1) ATE324887T1 (de)
AU (1) AU2003211195B2 (de)
BG (1) BG108904A (de)
BR (1) BR0303384A (de)
CA (1) CA2459834A1 (de)
CY (1) CY1106129T1 (de)
CZ (1) CZ2004661A3 (de)
DE (1) DE60305018T2 (de)
DK (1) DK1490049T3 (de)
EA (1) EA008350B1 (de)
EE (1) EE200400069A (de)
ES (2) ES2263009T3 (de)
HK (1) HK1075390A1 (de)
HR (1) HRP20040165B1 (de)
HU (1) HU0200980D0 (de)
IL (2) IL160486A0 (de)
IS (1) IS2392B (de)
LT (1) LT5255B (de)
LV (1) LV13281B (de)
MX (1) MXPA04008919A (de)
NO (1) NO20034998D0 (de)
PL (1) PL368902A1 (de)
PT (1) PT1490049E (de)
SI (1) SI1490049T1 (de)
SK (1) SK2222004A3 (de)
TR (1) TR200401036T1 (de)
UA (1) UA77506C2 (de)
WO (1) WO2003075914A1 (de)
YU (1) YU91203A (de)
ZA (1) ZA200408056B (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005039639A2 (en) * 2003-10-10 2005-05-06 Solvay Pharmaceuticals Gmbh Pharmaceutical composition comprising a selective i1 imidazoline receptor agonist and an angiotensin ii receptor blocker
DE102004002638A1 (de) * 2004-01-19 2005-08-18 Merck Patent Gmbh Kombinationen von Serotonin-Wiederaufnahme-Hemmern und Imidazolin-I2-Agonisten
EP2008653A1 (de) * 2007-06-28 2008-12-31 Charité-Universitätsmedizin Berlin Serotonerge Verbindungen zur Behandlung neuronaler Krankheiten

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1552012A (en) 1975-12-16 1979-09-05 Du Pont Canada Process for the treatment of comminuted oats
CZ291440B6 (cs) * 1997-07-08 2003-03-12 H. Lundbeck A/S Způsob výroby citalopramu
WO1998019512A2 (en) * 1997-11-11 1998-05-14 H. Lundbeck A/S Method for the preparation of citalopram
US6333357B1 (en) * 1999-11-05 2001-12-25 Be Able, Llc Behavior chemotherapy

Also Published As

Publication number Publication date
NO20034998D0 (no) 2003-11-10
CA2459834A1 (en) 2003-09-18
ES2263009T3 (es) 2006-12-01
HRP20040165B1 (en) 2007-08-31
IL160486A0 (en) 2004-07-25
UA77506C2 (en) 2006-12-15
JP2005519945A (ja) 2005-07-07
SK2222004A3 (en) 2004-08-03
KR100718368B1 (ko) 2007-05-14
AU2003211195A2 (en) 2003-09-22
EA008350B1 (ru) 2007-04-27
IL160486A (en) 2008-06-05
CN1259912C (zh) 2006-06-21
LT2004049A (en) 2005-03-25
EP1490049A1 (de) 2004-12-29
ES2238939A1 (es) 2005-09-01
TR200401036T1 (tr) 2005-10-21
BG108904A (en) 2006-04-28
AU2003211195A1 (en) 2003-09-22
US20050065209A1 (en) 2005-03-24
MXPA04008919A (es) 2004-11-26
IS2392B (is) 2008-08-15
IS7418A (is) 2004-08-20
DE60305018T2 (de) 2006-11-30
ES2238939B2 (es) 2006-04-16
EE200400069A (et) 2004-08-16
US7141604B2 (en) 2006-11-28
PT1490049E (pt) 2006-08-31
YU91203A (sh) 2006-08-17
KR20040090949A (ko) 2004-10-27
LV13281B (en) 2005-09-20
PL368902A1 (en) 2005-04-04
AU2003211195B2 (en) 2007-10-18
HRP20040165A2 (en) 2004-10-31
DK1490049T3 (da) 2006-08-21
LT5255B (lt) 2005-08-25
ATE324887T1 (de) 2006-06-15
WO2003075914A1 (en) 2003-09-18
EA200401147A1 (ru) 2005-02-24
CY1106129T1 (el) 2011-06-08
HK1075390A1 (en) 2005-12-16
ZA200408056B (en) 2005-10-10
HU0200980D0 (de) 2002-05-29
SI1490049T1 (sl) 2006-10-31
CN1568183A (zh) 2005-01-19
EP1490049B1 (de) 2006-05-03
CZ2004661A3 (cs) 2004-10-13
BR0303384A (pt) 2004-03-30

Similar Documents

Publication Publication Date Title
MXPA05004247A (es) Cromonas y derivados de cromona y usos de los mismos.
HUP0202570A1 (hu) Izoflavonokat és analogonjait tartalmazó készítmények és terápiás alkalmazásuk
NO20052739L (no) CCR5-antagonister som medikamenter
HK1080459A1 (en) Novel pyrimidineamide derivatives and the use thereof
AU2003297048A8 (en) Cyclohexyl compounds as ccr5 antagonists
WO2004030611A3 (en) Non-nucleoside reverse transcriptase inhibitors
ATE402176T1 (de) Pyrrolidin- und azetidinverbindungen alsccr5- antagonisten
WO2004073615A8 (en) Deazaflavin compounds and methods of use thereof
NO20054346L (no) Sammensetninger og fremgangsmater for forebygging og behandling av endotoksinrelaterte sykdommer og tilstander
DE60026491D1 (de) Melagatran zur behandlung von entzündungen
HUP0401633A2 (hu) Irbesartan alkalmazása pulmonális magas vérnyomás megelőzésére vagy kezelésére alkalmas gyógyszerkészítmény előállítására
HK1075390A1 (en) Citalopram for the treatment of elevated blood pressure
FR2860234B1 (fr) Nouveaux derives 666 du thioxylose
DE60226126D1 (de) Verwendung von gamma-gt inhibitoren zur behandlung von chronischen degenerativerkrankungen
DE60222662D1 (de) Verwendung von l-azetylcarnitin zur herstellung eines medikaments zur präventiven post-chirurgischen schmerzbehandlung
DE60216090D1 (de) Verwendung von l-acetylcarnitin zur herstellung eines medikaments zur behandlung von anhedonia
SE0202287D0 (sv) New compounds
WO2004071383A3 (en) New pharmaceutical compositions based on anticholinergics and inhibitors of tnf alpha synthesis or action
EA200701086A1 (ru) Производные изоксазола, их фармацевтические композиции и способ лечения невропатической боли

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee